Nedocromil sodium in obstructive airways disease: effect on symptoms and plasma protein leakage in sputum.

@article{Schoonbrood1997NedocromilSI,
  title={Nedocromil sodium in obstructive airways disease: effect on symptoms and plasma protein leakage in sputum.},
  author={D. Schoonbrood and T. Out and A. Hart and F. Habets and C. Roos and H. Jansen},
  journal={The European respiratory journal},
  year={1997},
  volume={10 7},
  pages={
          1500-6
        }
}
In patients with asthma or chronic obstructive pulmonary disease, there is chronic airway inflammation with increased leakage of plasma proteins into the airway lumen, which can be reduced by inhaled glucocorticosteroids. Nedocromil sodium is an anti-inflammatory drug, and we questioned whether it also affects the leakage of plasma proteins. In a double-blind placebo-controlled study we investigated the effect of 12 weeks of treatment with nedocromil on forced expiratory volume in one second… Expand
6 Citations

References

SHOWING 1-10 OF 36 REFERENCES
Plasma protein leakage and local secretion of proteins assessed in sputum in asthma and COPD. The effect of inhaled corticosteroids.
Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids.
Effects of nedocromil sodium on allergen-induced rhinitis in humans.
Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol.
Effects of methylprednisolone on sputum biochemical components in asthmatic bronchitis.
Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects
...
1
2
3
4
...